Drug:
Reaction: PRODUCT USE ISSUE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26542971 |
US |
77 | 2 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 102 | 26543160 |
US |
20 | |
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 103 | 26543659 |
US |
46 | 2 |
Therapeutic product effect incomplete, Drug interaction, Product use issue, |
||||
SEBETRALSTAT, BEROTRALSTAT HYDROCHLORIDE, |
||||
| 104 | 26543770 |
US |
1 | |
Product quality issue, Product use issue, Product dose omission issue, Medication error, Memory impairment, Drooling, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 105 | 26543789 |
US |
1 | |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 106 | 26543799 |
US |
36 | 2 |
Product use issue, Emergency care, Emergency care, |
||||
EPINEPHRINE, ADRENALINUM, ECALLANTIDE, |
||||
| 107 | 26543978 |
US |
1 | |
Product use issue, Off label use, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 108 | 26543988 |
US |
73 | 1 |
Glaucoma, Product use issue, |
||||
DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, BIMATOPROST, BIMATOPROST, BIMATOPROST, BIMATOPROST, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE, DEXAMETHASONE, DEXAMETHASONE, DEXAMETHASONE, DEXAMETHASONE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 109 | 26544045 |
US |
71 | 1 |
Dizziness, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, LISINOPRIL, |
||||
| 110 | 26544190 |
15 | 2 | |
Intentional overdose, Blood test abnormal, Product use issue, Vomiting, Epigastric discomfort, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 111 | 26544338 |
36 | ||
Seizure, Decreased appetite, Weight decreased, Food refusal, Product use issue, Anticonvulsant drug level increased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, DIVALPROEX SODIUM, |
||||
| 112 | 26544604 |
EU |
64 | 1 |
Drug ineffective, Product use issue, |
||||
EPINEPHRINE, TRANEXAMIC ACID, |
||||
| 113 | 26544728 |
CN |
49 | 2 |
Myelosuppression, Blood potassium decreased, Blood albumin decreased, Blood sodium decreased, Calcium ionised decreased, Product use issue, Blood chloride decreased, Protein total decreased, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 114 | 26544756 |
EU |
53 | 2 |
Neutropenia, Neutropenia, Neutropenia, Ascites, Malignant neoplasm progression, Product use issue, Tumour marker increased, |
||||
TRIFLURIDINE AND TIPIRACIL, BEVACIZUMAB, |
||||
| 115 | 26544853 |
US |
69 | 1 |
Haemoglobin decreased, Haematological infection, Nausea, Vomiting, Product use issue, |
||||
DAROLUTAMIDE, |
||||
| 116 | 26544949 |
US |
2 | |
Gastrointestinal motility disorder, Aspiration, Abdominal pain upper, Vomiting, Product use issue, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 117 | 26544977 |
US |
||
Product use issue, No adverse event, |
||||
SITAGLIPTIN PHOSPHATE, |
||||
| 118 | 26544994 |
47 | 2 | |
Asthenia, Dehydration, Diarrhoea, Product use issue, |
||||
TIRZEPATIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 119 | 26545010 |
79 | 2 | |
Product use issue, |
||||
MAVACAMTEN, |
||||
| 120 | 26545023 |
IL |
14 | 1 |
Jarisch-Herxheimer reaction, Product use issue, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 121 | 26545024 |
US |
77 | 2 |
Haemolytic anaemia, Product use issue, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 122 | 26545063 |
US |
77 | 2 |
Haemolytic anaemia, Product use issue, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 123 | 26545158 |
US |
64 | 1 |
Loss of consciousness, Product use issue, Decreased interest, Depression, Anxiety, Apathy, Insurance issue, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, SERTRALINE, |
||||
| 124 | 26545195 |
US |
76 | 2 |
Abdominal discomfort, Alopecia, Product use issue, Cataract, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 125 | 26545346 |
US |
66 | 2 |
Withdrawal syndrome, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 126 | 26545722 |
US |
27 | 1 |
Panic attack, Anxiety, Product use issue, |
||||
DEUTETRABENAZINE, |
||||
| 127 | 26545888 |
US |
74 | 2 |
Feeding disorder, Muscle spasms, Abnormal faeces, Faeces discoloured, Mobility decreased, Pain, Hiatus hernia, Dyspnoea, Balance disorder, Limb discomfort, Product use issue, Fatigue, Dysgeusia, Gastrooesophageal reflux disease, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 128 | 26546247 |
US |
1 | |
Dementia Alzheimer^s type, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 129 | 26546276 |
US |
43 | 1 |
No adverse event, Product use issue, |
||||
VORTIOXETINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CLONAZEPAM, FLUCONAZOLE, AMPHETAMINE, |
||||
| 130 | 26546668 |
US |
48 | 2 |
Product use in unapproved indication, Product use issue, |
||||
TEMOZOLOMIDE, LENVATINIB, PEMBROLIZUMAB, |
||||
| 131 | 26554548 |
|||
Product use issue, Pain, |
||||
MORPHINE SULFATE, |
||||
| 132 | 26554917 |
32 | 2 | |
Application site mass, Product use issue, |
||||
| 133 | 26535904 |
EU |
16 | |
Intentional overdose, Product use issue, Poisoning, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 134 | 26535954 |
US |
61 | 2 |
Product dose omission issue, Product use issue, |
||||
AZILSARTAN KAMEDOXOMIL, |
||||
| 135 | 26535959 |
US |
1 | |
Inability to afford medication, Product dose omission issue, Product use issue, |
||||
AZILSARTAN KAMEDOXOMIL, |
||||
| 136 | 26536192 |
ZA |
13 | 2 |
Disseminated mucormycosis, Product use issue, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, |
||||
| 137 | 26536325 |
US |
75 | 2 |
Joint swelling, Arthralgia, Product use issue, |
||||
ABATACEPT, |
||||
| 138 | 26536874 |
US |
45 | 1 |
Multiple sclerosis relapse, Fall, Product dose omission issue, Product use issue, Hand fracture, Drug ineffective, Musculoskeletal disorder, |
||||
OFATUMUMAB, |
||||
| 139 | 26536890 |
US |
78 | 2 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 140 | 26536920 |
CA |
2 | |
Psoriatic arthropathy, Injection site paraesthesia, Injection site pain, Condition aggravated, Fatigue, Dental caries, Product use issue, Joint deformity, Off label use, Treatment noncompliance, Disease recurrence, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PULSATILLA, EUPHORBIUM, ALLIUM CEPA, HISTAMINUM, LUFFA OPERCULATA, SABADILLA, HEPAR SULFUR., |
||||
| 141 | 26536973 |
US |
75 | 2 |
Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 142 | 26537143 |
US |
||
No adverse event, Product use issue, |
||||
VORTIOXETINE, |
||||
| 143 | 26537242 |
US |
74 | 1 |
Hot flush, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 144 | 26537295 |
US |
2 | |
Intentional product misuse, Product use issue, |
||||
| 145 | 26537299 |
US |
63 | 2 |
Intercepted product storage error, Product use issue, Asthma, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 146 | 26537366 |
US |
15 | 1 |
Neurological decompensation, Pharyngeal mass, Nasal cavity mass, Skin mass, Skin lesion, Bone marrow disorder, Post transplant lymphoproliferative disorder, Histiocytic sarcoma, Metastases to meninges, Metastases to lung, Metastases to liver, Metastases to spleen, Product use issue, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 147 | 26537603 |
EU |
15 | |
Intentional overdose, Product use issue, Poisoning, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 148 | 26537623 |
US |
||
Paraesthesia, Product use issue, |
||||
ESTRADIOL, |
||||
| 149 | 26537707 |
EU |
15 | |
Intentional overdose, Product use issue, Liver function test increased, Poisoning, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 150 | 26537747 |
EU |
13 | |
Overdose, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 151 | 26537974 |
US |
29 | 2 |
Product use issue, |
||||
| 152 | 26537991 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Abdominal pain, Abdominal pain upper, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Breast cancer stage III, Chest pain, Condition aggravated, Decreased appetite, Diarrhoea, Disability, Dizziness, Duodenal ulcer perforation, Dyspnoea, Nausea, Pruritus, Osteoarthritis, Pneumonia, Product use issue, Fatigue, Bronchitis, Grip strength decreased, Oedema, Drug hypersensitivity, Seronegative arthritis, Gait disturbance, Intentional product use issue, Insomnia, Adverse drug reaction, Therapeutic product effect incomplete, Amnesia, Therapeutic response decreased, Pyrexia, Treatment failure, Adjustment disorder with depressed mood, Liver function test increased, Muscular weakness, Dislocation of vertebra, Therapeutic product effect decreased, Upper respiratory tract infection, Hepatic enzyme increased, Foot deformity, Sciatica, Spondylitis, Mobility decreased, Oedema peripheral, Musculoskeletal stiffness, Rheumatic fever, Injury, Joint dislocation, Sinusitis, Headache, Swollen joint count increased, Delirium, Visual impairment, Weight decreased, C-reactive protein increased, Hypersensitivity, Osteoporosis, Discomfort, Tachycardia, Hypertension, Contraindicated product administered, Joint range of motion decreased, Drug tolerance decreased, Retinitis, Blood cholesterol increased, Depression, Drug-induced liver injury, Drug ineffective, Vomiting, Helicobacter infection, Hypoaesthesia, Infection, Infusion related reaction, Joint swelling, Live birth, Liver injury, Malaise, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Off label use, Pain, Pemphigus, Pericarditis, Peripheral swelling, Product use in unapproved indication, Psoriasis, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Abdominal discomfort, Walking aid user, Wheezing, Wound, Wound infection, Exposure during pregnancy, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Prescribed overdose, Rheumatoid factor positive, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Therapy non-responder, Treatment noncompliance, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CANDESARTAN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, SARILUMAB, PREGABALIN, PREGABALIN, PREDNISONE, TRIPROLIDINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, OXYCODONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, VITAMIN C, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, APREMILAST, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, NAPROXEN, NAPROXEN SODIUM, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREGABALIN, SARILUMAB, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VEDOLIZUMAB, |
||||
| 153 | 26538047 |
NZ |
||
Dizziness, Defaecation urgency, Abdominal distension, Product use issue, |
||||
SEMAGLUTIDE, |
||||
| 154 | 26538495 |
83 | 1 | |
Thyroid disorder, Product use issue, Product dose omission issue, |
||||
| 155 | 26538679 |
AU |
1 | |
Crohn^s disease, Product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 156 | 26539254 |
CA |
2 | |
Immunodeficiency, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Infusion related reaction, Joint swelling, Pain, Intentional product misuse, Exposure during pregnancy, Off label use, Overdose, Prescribed overdose, Product use issue, |
||||
LAMIVUDINE, LAMIVUDINE ORAL, BUPROPION, BUPROPION, BUPROPION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ABACAVIR SULFATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, PANTOPRAZOLE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, CLONIDINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, DOLUTEGRAVIR SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 157 | 26539586 |
US |
73 | 2 |
Eye pain, Product use issue, |
||||
ACOLTREMON, ACOLTREMON, CELECOXIB, GABAPENTIN, |
||||
| 158 | 26540102 |
US |
55 | 2 |
Eye pain, Product use issue, |
||||
ACOLTREMON, |
||||
| 159 | 26540204 |
US |
60 | 2 |
Adverse drug reaction, Product use issue, |
||||
ABATACEPT, |
||||
| 160 | 26540322 |
US |
63 | 2 |
Unevaluable event, Product use issue, |
||||
ACOLTREMON, |
||||
| 161 | 26540428 |
US |
2 | |
Eye swelling, Intentional overdose, Product use issue, |
||||
ACOLTREMON, |
||||
| 162 | 26540688 |
|||
Cell death, Product use issue, |
||||
DAROLUTAMIDE, DAROLUTAMIDE, |
||||
| 163 | 26540711 |
11 | ||
Pulmonary valve incompetence, Product use issue, |
||||
FENFLURAMINE, LEVETIRACETAM, MIDAZOLAM, DIAZEPAM, DIAZEPAM, CLOBAZAM, ETHOSUXIMIDE, |
||||
| 164 | 26540952 |
AU |
63 | |
Metastatic neoplasm, Lower respiratory tract infection, Non-small cell lung cancer, Lung opacity, Product use issue, Therapy interrupted, Positron emission tomogram abnormal, |
||||
OSIMERTINIB, |
||||
| 165 | 26541189 |
US |
78 | 1 |
Product use issue, |
||||
LENALIDOMIDE, |
||||
| 166 | 26541486 |
US |
38 | 2 |
Eye irritation, Product use issue, |
||||
ACOLTREMON, |
||||
| 167 | 26545933 |
|||
Product use issue, Pain, |
||||
| 168 | 26531175 |
US |
67 | 1 |
Confusional state, Product use issue, Incorrect dose administered, Inappropriate schedule of product administration, |
||||
RIPRETINIB, RIPRETINIB, |
||||
| 169 | 26531362 |
US |
||
Product use issue, Drug effect less than expected, |
||||
ADAPALENE, ADAPLANE 0.1%, |
||||
| 170 | 26531409 |
US |
2 | |
Memory impairment, Product use issue, |
||||
DAPAGLIFLOZIN, |
||||
| 171 | 26531435 |
US |
||
Product use issue, Product distribution issue, |
||||
ISOTRETINOIN, |
||||
| 172 | 26531578 |
US |
1 | |
Hallucination, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 173 | 26531646 |
US |
44 | 1 |
Dialysis, Laboratory test abnormal, Product use issue, |
||||
TACROLIMUS, |
||||
| 174 | 26531750 |
US |
2 | |
Product use issue, |
||||
| 175 | 26531852 |
US |
||
Drug ineffective, Product use issue, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PENICILLIN G BENZATHINE, |
||||
| 176 | 26531958 |
US |
2 | |
Product use complaint, Product use issue, |
||||
GABAPENTIN, |
||||
| 177 | 26532053 |
US |
71 | 1 |
Agitation, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 178 | 26532055 |
US |
76 | 1 |
Laboratory test abnormal, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, ALBUTEROL SULFATE, ALBUTEROL, BICALUTAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREDNISONE, |
||||
| 179 | 26532071 |
US |
||
Product dose omission issue, Product use issue, |
||||
GABAPENTIN, |
||||
| 180 | 26532251 |
11 | ||
Injection site erythema, Product use issue, |
||||
OLEZARSEN SODIUM, HYDROXYZINE, MOMETASONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, SEMAGLUTIDE, |
||||
| 181 | 26532336 |
US |
2 | |
Product use issue, |
||||
CABOTEGRAVIR SODIUM, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 182 | 26532468 |
US |
||
Insurance issue, Product use issue, |
||||
| 183 | 26532718 |
US |
||
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 184 | 26532736 |
US |
||
Product use issue, Injection site erythema, Injection site pruritus, Injection site irritation, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 185 | 26533024 |
US |
2 | |
Dyspnoea, Product use issue, |
||||
| 186 | 26533073 |
EU |
81 | 2 |
Cardiac failure, Multiple fractures, Hip fracture, Fall, Rib fracture, Hyponatraemia, Product use issue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, POMALIDOMIDE, |
||||
| 187 | 26533413 |
US |
63 | |
Product use issue, |
||||
AMBRISENTAN, AMBRISENTAN, AMBRISENTAN, FUROSEMIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, LORAZEPAM, SILDENAFIL CITRATE, |
||||
| 188 | 26533852 |
|||
Product use issue, |
||||
QUETIAPINE, |
||||
| 189 | 26533860 |
EU |
75 | 1 |
Supraventricular tachycardia, Ventricular dysfunction, Product use issue, |
||||
TRASTUZUMAB, TRASTUZUMAB, CARBOPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 190 | 26533879 |
US |
79 | 2 |
Deafness, Drug ineffective, Ear infection, Insomnia, Product use issue, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, |
||||
| 191 | 26534124 |
EU |
68 | 1 |
Optic ischaemic neuropathy, Product use issue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 192 | 26534139 |
US |
2 | |
Device malfunction, Product use issue, Device delivery system issue, |
||||
| 193 | 26534262 |
US |
||
Infection, Cystic fibrosis, Product use issue, |
||||
PANCRELIPASE, ALBUTEROL SULFATE, FERROUS SULFATE, CYPROHEPTADINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LORATADINE, LORATADINE ORAL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, DORNASE ALFA, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 194 | 26534264 |
US |
69 | 2 |
Influenza, Overweight, Product use issue, |
||||
VORTIOXETINE, |
||||
| 195 | 26534423 |
US |
1 | |
Product use issue, |
||||
LATANOPROST, |
||||
| 196 | 26534496 |
US |
||
Drug withdrawal syndrome, Product use issue, |
||||
ZOLPIDEM TARTRATE, |
||||
| 197 | 26534562 |
US |
2 | |
Product use issue, |
||||
TIRZEPATIDE, |
||||
| 198 | 26534642 |
|||
Inappropriate schedule of product administration, Product use issue, Device use issue, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 199 | 26534672 |
67 | 2 | |
Hospitalisation, Product use issue, |
||||
AVACOPAN, |
||||
| 200 | 26534679 |
EU |
12 | 2 |
Serotonin syndrome, Product use issue, Drug interaction, Neuroleptic malignant syndrome, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28